Log in

Vanishing white matter disease: imaging, clinical and molecular correlation in Brazilian families

  • Diagnostic Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract  

Purpose

To characterize Vanishing White Matter Disease (VWM) cases from a Brazilian University Tertiary hospital, focusing on brain magnetic resonance image (MRI) aspects, clinical and molecular data.

Methods

Medical records and brain MRI of 13 genetically confirmed VWM patients were reviewed. Epidemiological data such as age at symptom onset, gender and main symptoms were analyzed, along with genetic mutations and MRI characteristics, such as the distribution of white matter lesions and atrophy.

Results

The majority of patients were female, with the age of symptom onset ranging from 1 year and 6 months to 40 years. All mutations were identified in the EIF2B5 gene, the most prevalent being c.338G > A (p.Arg113His), and a novel mutation related to the disease was discovered, c.1051G > A (p.Gly351Ser). Trauma or infection were significant triggers. The most frequent symptoms were ataxia and limb spasticity. All MRI scans displayed deep white matter involvement, cystic degeneration, with U-fibers relatively spared and a predilection for the frontoparietal region. Lesions in the corpus callosum and posterior fossa were present in all patients. Follow-up exams revealed the evolution of white matter lesions and cerebral atrophy, which correlated with clinical deterioration.

Conclusions

VWM affects various age groups, with a significant clinical and genetic variability. A novel mutation associated with the disease is highlighted. MRI reveals a typical pattern of white matter involvement, characterized by diffuse lesions in the periventricular and deep regions, with subsequent extension to the subcortical areas, accompanied by cystic degeneration, and plays a crucial role in diagnosis and follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Data Availability

I declare the availability of the patient data from this study.

References

  1. van der Knaap MS, Schiffmann R, Mochel F et al (2019) Diagnosis, prognosis, and treatment of leukodystrophies. Lancet Neurol 18:962–972. https://doi.org/10.1016/S1474-4422(19)30143-7

    Article  PubMed  Google Scholar 

  2. Van der Knaap MS, Leegwater PAJ, Konst AA et al (2002) Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 51(2):264–270. https://doi.org/10.1002/ana.10112

    Article  CAS  PubMed  Google Scholar 

  3. Souza MST, Kok F (2005) Leucoencefalopatia com substância branca evanescente. Master Dissertation. Faculdade de Medicina da Universidade de São Paulo. https://doi.org/10.11606/D.5.2005.tde-17042006-094726

  4. Van der Knaap MS, Kamphorst W, Barth PG et al (1998) Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 51:540–547. https://doi.org/10.1212/wnl.51.2.540

    Article  PubMed  Google Scholar 

  5. Leegwater PAJ, Konst AAM, Kuyt B et al (1999) The Gene for Leukoencephalopathy with Vanishing White Matter Is Located on Chromosome 3q27. Am J Hum Genet 65:728–734. https://doi.org/10.1086/302548

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Raini G, Sharet R, Herrero M et al (2017) Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease. J Neurochem 141(5):694–707. https://doi.org/10.1111/jnc.14024

  7. Leegwater PAJ, Pronk JC, van der Knaap MS (2003) Leukoencephalopathy with vanishing white matter: From magnetic resonance imaging pattern to five genes. J Child Neurol 18:639–645. https://doi.org/10.1177/08830738030180091101

    Article  PubMed  Google Scholar 

  8. Hamilton EMC, van der Lei HDW, Vermeulen G et al (2018) (2018) Natural History of Vanishing White Matter. Ann Neurol 84:274–288. https://doi.org/10.1002/ana.25287

    Article  PubMed  PubMed Central  Google Scholar 

  9. van der Knaap MS, van Berkel CGM, Herms J et al (2003) eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet 73:1199–1207. https://doi.org/10.1086/379524

    Article  PubMed  PubMed Central  Google Scholar 

  10. La Piana R, Vanderver A, van der Knaap MS et al (2012) Adult-Onset Vanishing White Matter Disease Due to a Novel EIF2B3 Mutation. Arch Neurol 69(6):765–768. https://doi.org/10.1001/archneurol.2011.1942

    Article  PubMed  PubMed Central  Google Scholar 

  11. Fontenelle LMC, Scheper GC, Brandão L et al (2008) Atypical presentation of vanishing White matter disease. Arq Neuropsiquiatr 66(3-A):549–551. https://doi.org/10.1590/S0004-282X2008000400022

    Article  PubMed  Google Scholar 

  12. Rosemberg S, Leite CC, Arita F et al (2002) Leukoencephalopathy with vanishing white matter: report of four cases from three unrelated Brazilian families. Brain Develop 24:250–256. https://doi.org/10.1016/s0387-7604(02)00034-7

    Article  Google Scholar 

  13. van der Knaap MS, Pronk JC, Scheper GC (2006) Vanishing white matter disease. Lancet Neurol 5(5):413–423. https://doi.org/10.1016/S1474-4422(06)70440-9

    Article  PubMed  Google Scholar 

  14. van der Knaap MS, Barth PG, Gabreels FJ et al (1997) A new leukoencephalopathy with vanishing white matter. Neurology 48(4):845–855. https://doi.org/10.1212/wnl.48.4.845

    Article  PubMed  Google Scholar 

  15. Dooves S, Bugiani M, Postma NL et al (2016) Astrocytes are central in the pathomechanisms of vanishing white matter. J Clin Investig 126(4):1512–1524. https://doi.org/10.1172/JCI83908

    Article  PubMed  PubMed Central  Google Scholar 

  16. Stellinwerff MD, Al-Saady ML, van de Brug T et al (2021) MRI Natural History of the Leukodystrophy Vanishing White Matter. Radiology 300:671–680. https://doi.org/10.1148/radiol.2021210110

    Article  Google Scholar 

  17. Fogli A, Boespflug-Tanguy O (2006) The large spectrum of eIF2B-related diseases. Biochem Soc Trans 34:22–29. https://doi.org/10.1042/BST0340022

    Article  CAS  PubMed  Google Scholar 

  18. Pasquier F, Leys D, Weerts JG et al (1996) Inter and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36(5):268–272. https://doi.org/10.1159/000117270

    Article  CAS  PubMed  Google Scholar 

  19. Porciuncula R, Spada PKWDS, Bazzo Goulart KO (2018) Leucoencefalopatia com substância branca evanescente: um relato de caso. Rev Paul Pediatr 36(4):515–518. https://doi.org/10.1590/1984-0462/;2018;36;4;00001

    Article  PubMed  PubMed Central  Google Scholar 

  20. Labauge P, Horzinski L, Ayrignac X et al (2009) Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 132:2161–2169. https://doi.org/10.1093/brain/awp171

    Article  PubMed  Google Scholar 

  21. Ghezzi L, Scarpini E, Rango M et al (2012) A 66-year-old patient with vanishing white matter disease due to the p.ala87val eif2b3 mutation. Neurology 79(13):2077–78. https://doi.org/10.1212/WNL.0b013e3182749edc

    Article  PubMed  Google Scholar 

  22. Bugiani M, Boor I, Powers JM et al (2010) Leukoencephalopathy With Vanishing White Matter: A Review. J Neuropathol Exp Neurol 69(10):987–996. https://doi.org/10.1097/NEN.0b013e3181f2eafa

    Article  PubMed  Google Scholar 

  23. Mathis S, Scheper CG, Baumann N et al (2008) The ovarioleukodystrophy. Clin Neurol Neurosurg 110:1035–1037. https://doi.org/10.1016/j.clineuro.2008.06.002

    Article  PubMed  Google Scholar 

  24. Leegwater PAJ, Vermeulen G, Konst, et al (2001) Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 29(4):383–388. https://doi.org/10.1038/ng764

    Article  CAS  PubMed  Google Scholar 

  25. Schmidt JL, Pizzino A, Nicholl J et al (2020) Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing. Am J Med Genet A 182(8):1906–1912. https://doi.org/10.1002/ajmg.a.61641

    Article  PubMed  Google Scholar 

  26. Van der Knaap MS, Leegwater PAJ, van Berkel CGM et al (2004) Arg113His mutation in eIF2Bε as cause of leukoencephalopathy in adults. Neurology 62:1598–1600. https://doi.org/10.1212/01.WNL.0000123118.86746.FC

    Article  PubMed  Google Scholar 

  27. Fogli A, Schiffmann R, Bertini E et al (2004) The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 62:1509–1517. https://doi.org/10.1212/01.wnl.0000123259.67815.db

    Article  CAS  PubMed  Google Scholar 

  28. Cheon JE, Kim IO, Hwang YS et al (2002) Leukodystrophy in Children: A Pictorial Review of MR Imaging Features. Radiographics 22(3):461–476. https://doi.org/10.1148/radiographics.22.3.g02ma01461

    Article  PubMed  Google Scholar 

  29. Patay Z (2005) Diffusion-weighted MR imaging in leukodystrophies. Eur Radiol 15:2284–2303. https://doi.org/10.1007/s00330-005-2846-2

    Article  PubMed  Google Scholar 

  30. van der Lei HD, Steenweg ME, Barkhof F et al (2012) Characteristics of Early MRI in Children and Adolescents with Vanishing White Matter. Neuropediatrics 43(1):22–26. https://doi.org/10.1055/s-0032-1307456

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Thanks to Professor Dr. Marjo van der Knaap for the genetic analysis of the patients in this study.

Funding

No funding was received to assist with the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marianna Angelo Palmejani Albacete.

Ethics declarations

Ethics approval

This project follows resolution CNS 196/96 and was submitted for review by the Research Ethics Committee (CEP) of the Hospital das Clínicas of the Ribeirão Preto Medical School (HCFMRPUSP), obtaining approval under process number 11999/2016. No data collection occurred prior to CEP approval.

Informed consent

The Research Ethics Committee (CEP) of the Hospital das Clínicas of the Ribeirão Preto Medical School (HCFMRP-USP) was requested to waive the need for consent form, given that this is a retrospective study and the present work does not, in any way, alter the course of action already taken regarding the patient's condition. This study solely utilized data from examinations previously conducted at HC-FMRP. Furthermore, we also emphasize that we respect the preservation of absolute anonymity regarding patient information.

Competing interests

The authors have no competing interests to declare that are relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Albacete, M.A.P., Simão, G.N., Lourenço, C.M. et al. Vanishing white matter disease: imaging, clinical and molecular correlation in Brazilian families. Neuroradiology (2024). https://doi.org/10.1007/s00234-024-03405-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00234-024-03405-z

Keywords

Navigation